Unfortunately, many older agents causing CIPN remain the mainstay of cancer therapy
Anorexigenic effects and underlying mechanisms of GLP-1 receptor agonists Overview of GLP-1 receptor agonists GLP-1 receptor agonists (GLP-1RAs) are drugs developed for the treatment of type 2 diabetes and obesity
Seglutide 4mg/3ml Injection (Semaglutide) Generic Name: Semaglutide Strength: 4mg in 3ml solution Form: Multi-dose vial (not prefilled pen) Indications: Type 2 Diabetes Mellitus, Weight Loss (under doctors guidance) Therapeutic Class: GLP-1 Receptor Agonist Seglutide 4mg Injection is a weekly injectable semaglutide formulation available in vial form, intended for subcutaneous use in patients managing type 2 diabetes or obesity
Promising research in multiple fields Studies in endocrinology, immunology, and gastroenterology are all revealing the immune effects of GLP-1 receptor signaling
Members can order labs, imaging, and screening, message an in-house care team through the app, and get prescriptions delivered
